Patrick Farrant

Greater London. Greater London Legal Chronicle. May 21, 2022

RQ Bio’s $157 Million Licence With AstraZeneca

By Giulia Di Palma

In UK Taylor Vinters, advised on the matter. Taylor Vinters advised RQ Bio with a team including Patrick Farrant (Picture – Life Science & Health Care)....

This content is for members only.
Join Now

Already a member? Log in here

Greater London. Greater London Legal Chronicle. March 14, 2022

DIOSynVax’s $42 Million Deal With CEPI

By Giulia Di Palma

In UK Taylor Vinters, advised on the matter. Taylor Vinters advised DIOSynVax with a team including Patrick Farrant (Picture – IP&IT). DIOSynVax agreed for a $42m...

This content is for members only.
Join Now

Already a member? Log in here

Professional Beauty Systems’ Acquisition Of Nanogen

Triton Partners’ €1 Billion Closing of Triton Debt Opportunities Fund III

TeamViewer’s Acquisition of 1E

Kirkland Advises Blackstone on $1.5 Billion Investment in KKR

The Walt Disney Company’s $500 Million Senior Notes Offering

FirstGroup’s £500m Train Deal with Hitachi

Cicada Solar Limited’s $10 Million Financing Round

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

Stevens & Bolton Bolsters Corporate Tax Practice With Lateral Hire

Charles Russell Speechlys Announces the Opening of a New Office in Italy

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

RQ Bio’s $157 Million Licence With AstraZeneca

DIOSynVax’s $42 Million Deal With CEPI